![Domenico Petta](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Domenico Petta
Chief Executive Officer at S.A. 4M Europe SA
Domenico Petta active positions
Companies | Position | Start | End |
---|---|---|---|
S.A. 4M Europe SA
![]() S.A. 4M Europe SA Chemicals: SpecialtyProcess Industries S.A. 4M Europe SA offers decorative solutions. Its solutions include dust-free, non-slip, acid-resistant, antistatic, corrosion-resistant, heat conductive and waterproof. The company was founded in 1998 and is headquartered in Battice, Belgium. | Chief Executive Officer | 1997-12-31 | - |
Founder | 1997-12-31 | - | |
Targetome NV
![]() Targetome NV Pharmaceuticals: MajorHealth Technology Targetome SA operates is a biotech company which develops affinity-based targeted therapies against unmet medical needs with initial focus on pancreatic cancer and liver metastases. The firm develops antibody-drug conjugates. The company was founded by Edwin de Pauw and Vincent Castronovo in 2010 and is headquartered in Liege, Belgium. | Director/Board Member | 2013-07-24 | - |
Career history of Domenico Petta
Statistics
International
Belgium | 3 |
Operational
Chief Executive Officer | 1 |
Founder | 1 |
Director/Board Member | 1 |
Sectoral
Process Industries | 2 |
Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
S.A. 4M Europe SA
![]() S.A. 4M Europe SA Chemicals: SpecialtyProcess Industries S.A. 4M Europe SA offers decorative solutions. Its solutions include dust-free, non-slip, acid-resistant, antistatic, corrosion-resistant, heat conductive and waterproof. The company was founded in 1998 and is headquartered in Battice, Belgium. | Process Industries |
Targetome NV
![]() Targetome NV Pharmaceuticals: MajorHealth Technology Targetome SA operates is a biotech company which develops affinity-based targeted therapies against unmet medical needs with initial focus on pancreatic cancer and liver metastases. The firm develops antibody-drug conjugates. The company was founded by Edwin de Pauw and Vincent Castronovo in 2010 and is headquartered in Liege, Belgium. | Health Technology |
- Stock Market
- Insiders
- Domenico Petta
- Experience